Efficacy and safety of supramaximal titrated inhibition of renin-angiotensin-aldosterone system in idiopathic dilated cardiomyopathy.
about
New Agents in Treatment of Hyperkalemia: an Opportunity to Optimize Use of RAAS Inhibitors for Blood Pressure Control and Organ Protection in Patients with Chronic Kidney Disease.The appropriate dose of angiotensin-converting-enzyme inhibitors or angiotensin receptor blockers in patients with dilated cardiomyopathy. The higher, the better?ESC Heart Failure: a new journal aims to broaden heart failure views.
P2860
Efficacy and safety of supramaximal titrated inhibition of renin-angiotensin-aldosterone system in idiopathic dilated cardiomyopathy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Efficacy and safety of suprama ...... pathic dilated cardiomyopathy.
@en
type
label
Efficacy and safety of suprama ...... pathic dilated cardiomyopathy.
@en
prefLabel
Efficacy and safety of suprama ...... pathic dilated cardiomyopathy.
@en
P2093
P2860
P356
P1433
P1476
Efficacy and safety of suprama ...... pathic dilated cardiomyopathy.
@en
P2093
Jihua Feng
Kang Cheng
P2860
P304
P356
10.1002/EHF2.12042
P577
2015-07-14T00:00:00Z